Company intelligence / Profile preview

Stryker

Kalamazoo, Michigan, United Statescareers.stryker.com ↗

Ownership: Public · SYK
Employees: ~51000
Development stage: Commercial

Overview

Stryker’s products are widely used in hospitals and clinics globally. The company has a long track record of innovation in orthopedic implants/devices and surgical equipment. It has expanded into neurotechnology and minimally invasive surgery through acquisitions. Its products are commercialized worldwide with strong clinical adoption.

Therapeutic areas: OtherNeurologyRheumatology
Modalities: Device
Industry: Implantable Medical Devices

Drug pipeline

3 assets

cetylpyridinium chloride hydrate

Commercial

Indications: Infectious diseases

2 more assets in the full pipeline.

Request access →

Financials

Market cap: $106B
Total revenue: $6.6B
Enterprise value: $117.4B

Beyond the preview

Go deeper on Stryker.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stryker.

Explore the full profile